Clinical Trials

Phase I/II study of Dasatinib and Osimertinib (AZD9291) in patients with advanced non-small cell lung cancer with EGFR mutations


Study ID
Georgetown CA180-618

NCT Number
NCT02954523 (Click on the NCT number for more information about the trial)

Research Study Number
2017-0398

Principle Investigator
Dr. Martin Gutierrez

Phase
I/II

Sponsor
Georgetown University


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now